PARATEK PHARMACEUTICALS INC — Form D/A
PARATEK PHARMACEUTICALS INC of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2014-07-16. The offering totals $93.0M, of which $93.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-07-16
- Form: D/A
- Accession: 0001192482-14-000150
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $93.0M
- Amount sold: $93.0M
- Investors: 54
- Date of first sale: 2014-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-221025
Issuer
- Name: PARATEK PHARMACEUTICALS INC
- CIK: 0001037643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 75 KNEELAND STREET, BOSTON, MA, 02111
- Phone: (617) 275-0040
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| MICHAEL BIGHAM | Director | BOSTON, MA |
| Richard Lim | Director | BOSTON, MA |
| Evan Loh | Director | Boulder, CO |
| Beverly Armstrong | Executive Officer | Boston, MA |
| MICHAEL BIGHAM | Executive Officer | BOSTON, MA |
| Kathryn Boxmeyer | Executive Officer | Boston, MA |
| Sean M Johnston | Executive Officer | Boston, MA |
| Evan Loh | Executive Officer | Boulder, CO |
| Dennis Molnar | Executive Officer | Cambridge, MA |
| S. Ken Tanaka | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More